CETP gene polymorphisms and risk of coronary atherosclerosis in a Chinese population

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Wang, Jun ^a   Wang, Li Jun ^a   Zhong, Yong ^a   Gu, Ping ^a   Shao, Jia Qing ^a   Jiang, Shi Sen ^a   Gong, Jian Bin ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

CETP; Coronary atherosclerosis; Genetic mutation; HDL C

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHINA; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 84888261454     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-176     Document Type: Article

References (27)

1. Inflammation, atherosclerosis, and coronary artery disease. Hansson GK, N Engl J Med 2005 352 1685 1695 10.1056/NEJMra043430 15843671 (Pubitemid 40530235)
2. Detection and quantification of lipoprotein (a) in the arterial wall of 107 coronary bypass patients. Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisiegel U, Arteriosclerosis 1989 9 579 592 10.1161/01.ATV.9.5.579 2528948 (Pubitemid 19236892)
3. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Miller GJ, Miller NE, Lancet 1975 1 16 19 46338
4. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels. Hausenloy DJ, Yellon DM, Heart 2008 94 706 714 10.1136/hrt.2007.125401 18480348 (Pubitemid 351744686)
5. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. Tardif JC, Grégoire J, L'Allier PL, et al. JAMA 2007 297 1675 1682 10.1001/jama.297.15.jpc70004 17387133 (Pubitemid 46631626)
6. High-density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease. Riwanto M, Landmesser U, J Lipid Res in press
7. High-density lipoprotein binding toscavenger receptor-BI activates endothelial nitric oxide synthase. Yuhanna IS, Zhu Y, Cox BE, et al. Nat Med 2001 7 853 857 10.1038/89986 11433352 (Pubitemid 32691642)
8. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Brown ML, Inazu A, Hesler CB, et al. Nature 1989 342 448 451 10.1038/342448a0 2586614 (Pubitemid 19277523)
9. Therapeutic targets to raise HDL in patients at risk or with coronary artery disease. Lüscher TF, Von Eckardstein A, Simic B, Curr Vasc Pharmacol 2012 10 720 724 10.2174/157016112803520972 23259565
10. Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: genome wide analysis among 18 245 initially healthy women from the Women's genome health study. Ridker PM, Paré G, Parker AN, Zee RY, Miletich JP, Chasman DI, Circ Cardiovasc Genet 2009 2 26 33 10.1161/CIRCGENETICS.108.817304 20031564
11. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Barter PJ, Brewer HB Jr, Chapman MJ, Hennekens CH, Rader DJ, Tall AR, Arterioscler Thromb Vasc Biol 2003 23 160 167 10.1161/01.ATV.0000054658.91146.64 12588754 (Pubitemid 36231923)
12. A review of CETP and its relation to atherosclerosis. De Grooth GJ, Klerkx AH, Stroes ES, Stalenhoef AF, Kastelein JJ, Kuivenhoven JA, J Lipid Res 2004 45 1967 1974 10.1194/jlr.R400007-JLR200 15342674 (Pubitemid 40990890)
13. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. Thompson A, Di Angelantonio E, Sarwar N, et al. JAMA 2008 299 2777 2788 10.1001/jama.299.23.2777 18560005 (Pubitemid 351846853)
14. Physical activity modifies the effect of LPL, LIPC, and CETP polymorphisms on HDL-C levels and the risk of myocardial infarction in women of European ancestry. Ahmad T, Chasman DI, Buring JE, Lee IM, Ridker PM, Everett BM, Circ Cardiovasc Genet 2011 4 74 80 10.1161/CIRCGENETICS.110.957290 21252145
15. Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study. Dumitrescu L, Carty CL, Taylor K, et al. PLoS Genet 2011 7 1002138 10.1371/journal.pgen. 1002138 21738485
16. A confidence set inference method for identifying SNPs that regulate quantitative phenotypes. Papachristou C, Lin S, Hum Hered 2012 73 174 183 10.1159/000339178 22776981
17. Single nucleotide polymorphisms in CETP, SLC46A1, SLC19A1, CD36, BCMO1, APOA5, and ABCA1 are significant predictors of plasma HDL in healthy adults. Clifford AJ, Rincon G, Owens JE, et al. Lipids Health Dis 2013 12 66 10.1186/1476-511X-12-66 23656756
18. Association between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: a cross sectional study. Kashani Farid MA, Azizi F, Hedayati M, Daneshpour MS, Shamshiri AR, Siassi F, Lipids Health Dis 2010 9 96 10.1186/1476-511X-9-96 20822508
19. Association of two CETP polymorphisms with HDL levels in the Chinese obese population. Ruan X, Ma L, Wang S, et al. Obesity (Silver Spring) 2009 17 2196 2201 10.1038/oby.2009.138 19444232
20. Association of CETP Taq1B and -629C > A polymorphisms with coronary artery disease and lipid levels in the multi-ethnic Singaporean population. Lu Y, Tayebi N, Li H, Saha N, Yang H, Heng CK, Lipids Health Dis 2013 12 85 10.1186/1476-511X-12-85 23758630
21. Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis. Dullaart RP, Sluiter WJ, Pharmacogenomics 2008 9 747 763 10.2217/14622416.9.6.747 18518852
22. Cholesteryl ester transfer protein promoter single-nucleotide polymorphisms in Sp1-binding sites affect transcription and are associated with high-density lipoprotein cholesterol. Thompson JF, Lloyd DB, Lira ME, Milos PM, Clin Genet 2004 66 223 228 10.1111/j.1399-0004.2004.00289.x 15324321 (Pubitemid 39232785)
23. New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Dachet C, Poirier O, Cambien F, Chapman J, Rouis M, Arterioscler Thromb Vasc Biol 2000 20 507 515 10.1161/01.ATV.20.2.507 10669650 (Pubitemid 30086110)
24. The association of common SNPs and haplotypes in CETP gene with HDL cholesterol levels in Latvian population. Radovica I, Fridmanis D, Vaivade I, Nikitina-Zake L, Klovins J, PLoS One 2013 8 64191 10.1371/journal.pone.0064191 23675527
25. Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C/A polymorphism and a novel promoter variant are independently associated with CETP concentration. Klerkx AH, Tanck MW, Kastelein JJ, et al. Hum Mol Genet 2003 12 111 123 10.1093/hmg/ddg013 12499392 (Pubitemid 36124447)
26. Haploview: analysis and visualization of LD and haplotype maps. Barrett JC, Fry B, Maller J, Daly MJ, Bioinformatics 2005 21 263 265 10.1093/bioinformatics/bth457 15297300 (Pubitemid 40202029)
27. Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Lin DY, Zeng D, Millikan R, Genet Epidemiol 2005 29 299 312 10.1002/gepi.20098 16240443 (Pubitemid 41720949)